# Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2

> **NCT02943486** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Universidad Autónoma de Bucaramanga** · enrollment: 51 (estimated)

## Conditions studied

- Foot Ulcer, Diabetic

## Interventions

- **OTHER:** dac-MSCs
- **OTHER:** MSCs
- **DRUG:** Fitostimoline

## Key facts

- **NCT ID:** NCT02943486
- **Lead sponsor:** Universidad Autónoma de Bucaramanga
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2018-06
- **Final completion:** 2019-01
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2016-10-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02943486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02943486, "Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02943486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*